- Journalists Shed Light on Deadly Hantavirus Outbreak and a Crisis in the Nation’s ERs
- Is the horizon still bright for orthodontists?
- The Make America Healthy Again Movement Comes for Hospital Food
- What’s driving physicians to early retirement
- Why Tenet’s CEO says ASCs keep choosing USPI
- 12 recent hospital, health system president exits
- Hospitals embrace rapid opioid treatment in fentanyl era: Study
- Texas systems open 200-bed behavioral health center
- 32 health systems spending $5B on cancer care
- Sanford, North Memorial planned combination adds to Minnesota healthcare deal wave
- Lone Peak Dental Group acquires Arizona practice
- Inside Northwestern Medicine’s battle against surgeon burnout
- UT Austin launches Epic ahead of new academic medical center
- Ohio system names COO
- Buy, sell or fight: The new calculus of health system growth
- OpenAI’s growing healthcare footprint
- Tennessee optometrist pleads guilty to $6.9M Medicare fraud
- Why Cook County Health’s Medicaid coverage loss strategy is drawing attention
- Akron Children’s chosen for former Ohio college campus site
- Surgery Partners doubles down on orthopedics, robotics as total joint growth hits 14.6%
- The growing war over Anthem’s out-of-network penalty policy
- 3 PDS Health headlines to know in 1 week
- Remarks at the Conference on Financial Market Regulation
- Could ASCs help cardiology move past its ‘breaking point’?
- 3 programs expanding the anesthesia workforce in 2026
- Dad Jokes: Remarks at the 13th Annual Conference on Financial Markets Regulation
- UVM Health targets $300M in cuts, outpatient overhaul amid $280M deficit
- Maine behavioral health provider cites industry pressures in merger
- Dentists opening practices in 1 month
- The Aspen Group names new chief commercial officer
- RFK Jr. Launches Plan To Curb Antidepressant 'Overprescription'
- Georgia mental health provider adds after-hours outpatient program
- AI-augmented behavioral health provider Theris launches out of stealth
- 5 data breaches, settlements impacting cardiology
- Maine hospital adds stroke prevention, cardiac imaging services
- As new tech, AI sweeps the marketing world, Eversana Intouch’s new CEO is ‘comfortable in the gray’
- Sanford Health unveils deal to integrate Minnesota-area North Memorial Health, invest $600M
- Trump plans to fire FDA chief Marty Makary: report
- Trump plans to fire FDA chief Marty Makary: report
- Oregon governor signs behavioral health workforce expansion bills amid shortage
- Remarks at the Special Competitive Studies Project AI+ Expo
- Lawmakers, former FDA leaders and more rally behind mifepristone as Supreme Court weighs telemedicine access to abortion pill
- 5 DSOs making headlines
- Plant-Based Foods May Help Lower Risk of High Blood Pressure
- The ACA exchanges dominated Q1 earnings calls. Here's what payer, health system execs had to say
- Targeted Protein Degradation and Novel Modalities: Getting on the Frontline
- Gilead cranks up Yeztugo first-year sales forecast to $1B on 'unprecedented launch trajectory'
- Capricor Therapeutics files breach-of-contract lawsuit against US partner NS Pharma
- Op-ed: It's time to make more strategic bets on AI in healthcare
- Daiichi Sankyo takes $610M profit hit linked to ADC manufacturing overbuild
- Super Shoes Might Increase Risk Of Running Injuries, Study Says
- TV, Movies Offer Flawed Depictions Of Autism, Add To Delayed Diagnosis, Study Says
- Opioid OD Survivors Have Triple Rate Of Repeat Overdoses Than Previously Estimated
- Revisiting Pharma’s tariff reality
- A New Medicare Option For Weight Loss Drugs: What Older Americans Should Know
- Exposure Therapy Can Successfully Ease Peanut Allergies
- Listen: A Federal Agency Is After Workers’ Health Data, and Critics Are Alarmed
- In California Governor Race, Single-Payer Is a Litmus Test. There’s Still No Way To Pay for It.
- AbbVie’s Skyrizi beats out J&J’s Tremfya in April drug ad spending leaderboard
- Johnson & Johnson launches ‘Generation Fine’ depression project
- Pre-launch efforts linked to lasting drug awareness edge: report
- GSK tees up a Modern Family for meningitis messaging
- NYC invests $12M in overdose recovery workforce
- Aspen Dental to pay $2M to settle allegations of violating corporate dentistry laws
- Texas dental practice relocates into 6K-square-foot facility
- Medit launches global orthodontics division, acquires California training institute
- Pennsylvania enacts dental faculty bill
- Cruise Ship Hantavirus Outbreak Kills 3 as WHO Says Risk Is Low
- How policy, reimbursement incentives, could help healthcare address its climate footprint
- Remarks at the 13th Annual Conference on Financial Market Regulation
- 5 best practices for financially integrating behavioral health
- Fierce Pharma Asia—Summit’s surprise interim trial miss; UCB’s $2B Candid buy; J&J’s CAR-T cuts
- Amazon Pharmacy to offer home delivery for Novo Nordisk's Ozempic pill
- New York expands behavioral health data access in EHRs
- Staffing firm Cross Country Healthcare to be acquired by Knox Lane for $437M
- New Hampshire to receive $29.5M in Purdue opioid settlement
- Behavioral health leaders counter HHS ‘overprescribing’ narrative
- Clover Health's MA membership grows 51% year-over-year
- New Study Suggests The Brain Can Continue Learning While In An Unconscious State
- Health Tech Weekly Rundown: Tether rolls out medical AI for phones, wearables; Medaptus launches operational ‘command center’
- Pennsylvania sues Character.ai over AI chatbot allegedly presenting itself as licensed medical professional
- Angelini finds Catalyst for its US growth ambitions with $4.1B buyout
- FDA to reconsider shock rejection of cell therapy Ebvallo. Could uniQure be next?
- Every 1,000 Steps After Surgery Cuts Complication Risk, Study Finds
- Bullying and Politics Fuel Suicide Risk for LGBTQ+ Teens and Young Adults, Survey Finds
- Head Impacts May Disrupt Gut Health Even Without Concussion
- Class of Migraine Drug, CGRP Inhibitors, Has Added Benefit: Reduced Glaucoma Risk
- States Eye Aid to Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- That Discount at the Pharmacy Counter May Pack Hidden Costs
- Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up.
- Hims & Hers debuts its first AI care agent to interpret biomarker lab results
- Alnylam rebuked by FDA over efficacy claims on Amvuttra website
- Insulet CEO details ‘Scrubs’ device promotion win as it boosts awareness, education drive
- Oscar Health's profit hits $679M, membership rises in Q1
- Joint Commission, NACHC partner on training, new accreditation for community health centers
- Ardent Health touts outpatient growth, checked labor spend during hectic Q1
- FDA Authorizes Fruit-Flavored Vapes for Adults
- Sanofi asks to pull Tzield bid from FDA's controversial CNPV program: report
- FDA rolls out 1-day assessment pilot in bid to refocus inspection resources
- Nearly 8 in 10 employers say GLP-1 coverage drives up benefit costs: Business Group on Health
- Edibles + Alcohol Combo Poses Driving Risks Missed by Sobriety Tests
- Leapfrog Group's latest safety grades have far fewer low scores since removal of non-participating hospitals
- VR Training Helps Autistic People Navigate Police Encounters
- Novo CEO cites pricing 'sweet spot' as Wegovy pill debuts with $355M quarter
- Weight Loss Surgeries Fall More Than 20% As Patients Turn To GLP-1 Meds, Experts Say
- FDA blocks publication of COVID, shingles vaccine safety studies: NYT
- Bayer diagnoses how to build trust in cell and gene therapies
- Amwell boasts higher than expected renewals, retention despite Q1 revenue decline
- First Psych Ward Stay Signals Long-Term Mental Health Struggles For Nearly All Patients
- Why Melatonin Shouldn't Be A Bedtime Go-To For Kids
- Children Living Near Gas Stations Have Higher Cancer Risk, Study Finds
- The timing is right for psychedelics manufacturer Optimi Health's IPO
- HHS' Healthy Food Agenda Puts Hospitals On Notice About Patients' Meals
- A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know
- Trump’s Drug Strategy Aims To Bolster Addiction Services — Despite Gutting of Government Support
- Inside the gaps in fertility and surrogacy systems
- CVS execs say company on track to meet MA margin goals by 2028
- Facilitating Access to Trump Accounts
- Fixing Failures to Communicate
- Hinge Health lifts 2026 outlook after strong Q1 as it expands to new conditions
- For nonprofit hospitals, pricey management consultants haven't yielded better performances: study
- Supreme Court Issues Stay, Keeping Abortion Pill Mifepristone Available by Mail For Now
- Statement on Proposing Release for Semiannual Reporting
- Quarterly Questions: Statement on the Proposed Amendments to Allow Semiannual Reporting
- Statement on Proposing Semiannual Reporting
- Wellstar partners with BD to implement AI-driven medication management system
- Listen to the Latest ‘KFF Health News Minute’
- Newer Migraine Drugs Reduce Headache Days With Fewer Side Effects
- New Drug Combo Effective Against Treatment-Resistant IBD, Trials Show
- New Warning Labels Might Help People Cut Back On Drinking
- Ozempic Can Curb Cravings in Alcohol Use Disorder, Landmark Trial Finds
- US on the Brink of Losing Measles-free Status, Study Warns
- Delays in Visa Program Threaten Doctor Placements in Underserved Areas
- States Eye Aid To Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- Supreme Court Puts Brakes on Abortion Pill Restrictions
- FDA Green Lights Expanded Access to Pancreatic Cancer Drug, Daraxonrasib
- Online Misinformation Adding To Americans' Skin Cancer Risk, Survey Finds
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Social Media Videos, Easy Access Raise Risk of Teen Inhalant Use
- Staff Statement Regarding Pooled Employer Plans
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- 'Fitspirational' Posts Can Be More Harmful Than Motivational, Review Concludes
- Parents’ Stress Tied to Children’s Mental Health, New Survey Finds
- Surgeon Multitasking Increases Death Risk Of Organ Transplantees
- When Natural Disasters Strike, Another Crisis Hits Those Recovering From Opioid Addiction
- FDA Recalls Several Ghirardelli Powdered Beverages Over Potential Contamination
The Manhattan Institute is a respected center-right think tank best known for their City-Journal website. Chris Pope, a senior fellow at the Manhattan Institute, has written a thoughtful piece on managing skyrocketing Medicaid costs into the future:
https://thehill.com/opinion/healthcare/4022852-a-better-way-to-rein-in-medicaid/
A better way to rein in Medicaid
By Chris Pope - May 30, 2023Medicaid is two things at once: a health care benefit for poor individuals, and a system of federal grants that disproportionately profits wealthy states.
Over the past four decades, Medicaid spending has grown more than any other category of public expenditure. Republicans have tried to rein in the cost of the program with “block grants” and “per capita caps.” But these would leave states short of funds in recessions, threatening state budgets and coverage for low-income beneficiaries when assistance is most needed. As a result, Congress has repeatedly rejected these proposals — even under unified GOP control.
A better approach would be to gradually federalize responsibility for covering individuals that states must enroll in Medicaid, while leaving states to pay for whatever additional benefits they choose to provide out of their own funds.
Medicaid has been the fastest growing government program over recent years, expanding from 0.5 percent of gross domestic product in 1985 to 2.4 percent of GDP in 2022. This is partly due to the general increase in health care costs, but mostly the product of substantial expansions in eligibility. Medicare’s enrollment surged from 20 million in 1985 to 86 million in 2021 — an increase from 8 percent to 26 percent of the U.S. population.
Over that period, the expansion of Medicaid contributed to a decline from 15 percent to 11 percent in the proportion of the U.S. population that lacks health insurance. But one study estimated that for 60 percent of those newly enrolled, expansions of Medicaid coverage had simply served to displace private insurance.
Medicaid is largely structured and operated by states, with funding mostly provided by the federal government. States can claim between $1 and $9 in federal funds for every $1 they spend on the program for eligible beneficiaries, which gives them a great incentive to expand the program as much as they can. The wealthiest states with the deepest tax bases have been most able to take advantage of this arrangement: Alaska claimed $21,445 in federal Medicaid funding per resident in poverty in 2021, whereas Nevada received only $8,402. During economic expansions, states have used growing revenues to expand Medicaid, and repeatedly prodded Congress to bail them out in subsequent recessions.
For decades, congressional Republicans have sought to rein in Medicaid costs by capping federal matching aid each state can claim for each beneficiary. (This was how grants to states under the Social Security Act were all initially structured.) But this proposal has repeatedly run into a combination of substantive objections and political obstacles, which are unlikely to disappear.
Opponents have argued that capping Medicaid grants to states would threaten the funding of health care for the neediest beneficiaries. This problem would be particularly acute in recessions, when state tax revenues decline just as their Medicaid caseloads increase — exacerbating the bailout dynamic. It would also leave states in a bind if medical costs suddenly surged beyond their fiscal capacities. As proposed caps have been based on historical spending, traditionally low-spending states would have become subject to the tightest constraints. This has made per capita caps unpopular with many Republican governors as well as Democrats.
To meet these objections, the proposed caps considered (and rejected) by the Republican Congress in 2017 were so watered down that they would have been entirely ineffectual. They would have limited the growth of federal Medicaid grants to 3.7 percent per enrollee per year, even though spending had only grown at 2.0 percent per year over the previous 16 years. Nor would per enrollee caps have done anything to constrain the cost of expanding enrollment, which is the main driver of rising expenditure.
Reformers would achieve more by distributing Medicaid funds according to the needs of individuals, rather than in proportion to the resources that states are able to contribute.
To claim federal Medicaid funds, states are currently required to cover a core package of services (hospital, physician and nursing home care) for groups of mandatory beneficiaries (such as pregnant women, the disabled and children with incomes below the poverty line). They may also claim federal funds at the same matching rate to provide additional services (such as optical or dental care) and for expanding eligibility to individuals with incomes up to 380 percent of the federal poverty line.
Across the country, federal payments to states amount to 125 percent of the cost of mandatory Medicaid spending. But while federal assistance for mandatory Medicaid spending is fairly uniform across states, the wealthiest states claim several times more than the poorest in grants for optional benefits. Whereas Nevada in 2013 received federal payments covering 85 percent of the cost of benefits it was required to provide, the District of Columbia was able to claim 203 percent.
The core problem with Medicaid is the separation between control over the cost of the program (the scope of benefits, fees paid for them and the breadth of eligibility) and the responsibility for paying for it. Ideally, the federal government should directly operate and fully fund mandatory Medicaid benefits, and let states fully fund any additional benefits they choose to provide out of their own resources.
Such an arrangement would represent a big change from the status quo; thus, a more incremental reform path to get there is necessary.
To achieve this, federal payments to each state should be capped at either (1) 100 percent of the cost of providing core benefits to mandatory enrollees, or (2) the current per resident level of federal funding in nominal terms — whichever is higher. States should be allowed waivers to claim federal funds at a higher matching rate to fund mandatory spending by reducing federal aid claimed for optional spending by an equivalent amount.
This reform would focus federal Medicaid spending on the provision of core benefits for the neediest enrollees. Rather than leaving states short of funds in recessions when program costs increase, it would make the federal government largely responsible for costs resulting from increased enrollment among core eligibility groups in such circumstances.
Yet, such a reform would eliminate the incentive for states to expand the cost of Medicaid at the expense of the federal government. Over time, it would reduce real federal Medicaid spending by 20 percent, as inflation erodes the real value of grants to states where spending on optional benefits exceeds the full cost of mandatory spending. The reduction in federal spending would be limited to optional benefits and concentrated on the wealthiest states. By harmonizing benefits and reducing the disparity in assistance to states over time, this would facilitate the eventual full federalization of the program.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.













